Skip to main content
. 2016 Jan 5;10(5):556–565. doi: 10.1093/ecco-jcc/jjv243

Figure 2.

Figure 2

a. Lorenz curves displaying the proportions of inpatient healthcare utilisation during 2013 among all patients in each inflammatory bowel disease [IBD] group (n = 5690 Crohn’s disease [CD], n = 7409 ulcerative colitis [UC], and n = 817 inflammatory bowel disease unclassified [IBDU]). Inpatient healthcare utilisation for IBD was defined by the number of bed-days with IBD listed as primary discharge diagnosis. b. Lorenz curves displaying the proportions of inpatient healthcare utilisation defined by the number of bed-days with IBD listed as primary discharge diagnosis. Only patients who utilised inpatient care during 2013 were included in this Lorenz curve (n = 329 [CD], n = 156 [UC], and n = 28 [IBDU]).